Cerity Partners LLC Raises Stock Holdings in John Wiley & Sons, Inc. (NYSE:WLY)

Cerity Partners LLC boosted its stake in shares of John Wiley & Sons, Inc. (NYSE:WLY) by 84.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,760 shares of the company’s stock after buying an additional 7,222 shares during the quarter. Cerity Partners LLC’s holdings in John Wiley & Sons were worth $760,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Eagle Asset Management Inc. grew its stake in shares of John Wiley & Sons by 40.1% in the third quarter. Eagle Asset Management Inc. now owns 407,997 shares of the company’s stock valued at $21,273,000 after buying an additional 116,772 shares in the last quarter. Intech Investment Management LLC purchased a new position in John Wiley & Sons during the 3rd quarter valued at about $543,000. Arjuna Capital grew its position in John Wiley & Sons by 1.5% in the 3rd quarter. Arjuna Capital now owns 55,208 shares of the company’s stock valued at $2,664,000 after acquiring an additional 830 shares in the last quarter. Victory Capital Management Inc. increased its stake in John Wiley & Sons by 113.6% during the third quarter. Victory Capital Management Inc. now owns 35,762 shares of the company’s stock worth $1,726,000 after purchasing an additional 19,017 shares during the period. Finally, Atria Investments Inc increased its stake in John Wiley & Sons by 39.6% during the third quarter. Atria Investments Inc now owns 13,509 shares of the company’s stock worth $652,000 after purchasing an additional 3,833 shares during the period. 73.94% of the stock is currently owned by institutional investors and hedge funds.

John Wiley & Sons Trading Down 6.3 %

NYSE WLY opened at $46.36 on Friday. The company has a debt-to-equity ratio of 1.27, a quick ratio of 0.53 and a current ratio of 0.57. The firm has a market cap of $2.52 billion, a price-to-earnings ratio of -23.18 and a beta of 0.85. The firm has a 50 day simple moving average of $50.45 and a 200-day simple moving average of $45.83. John Wiley & Sons, Inc. has a one year low of $29.04 and a one year high of $53.96.

John Wiley & Sons (NYSE:WLY) last posted its quarterly earnings results on Thursday, December 5th. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.88 by $0.09. John Wiley & Sons had a positive return on equity of 21.59% and a negative net margin of 6.00%. The company had revenue of $426.60 million for the quarter, compared to analyst estimates of $420.00 million. The company’s quarterly revenue was down 13.4% compared to the same quarter last year.

John Wiley & Sons Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 24th. Investors of record on Tuesday, October 8th were paid a dividend of $0.352 per share. The ex-dividend date of this dividend was Tuesday, October 8th. This represents a $1.41 dividend on an annualized basis and a dividend yield of 3.04%. John Wiley & Sons’s payout ratio is currently -70.50%.

Insider Activity at John Wiley & Sons

In related news, EVP Danielle Mcmahan sold 2,318 shares of the business’s stock in a transaction that occurred on Tuesday, October 8th. The stock was sold at an average price of $49.41, for a total transaction of $114,532.38. Following the completion of the sale, the executive vice president now owns 8,978 shares in the company, valued at $443,602.98. The trade was a 20.52 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.62% of the stock is currently owned by corporate insiders.

About John Wiley & Sons

John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.